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Abstract
We present a brief overview of the use of beta-agonists in feeding stuff in Portugal in the last two decades.
Introduction
Beta-agonists are used in human and veterinary medicine for specific effects on smooth muscle. When 
misused at higher doses, they can also act as growth promoters by stimulating the increase of the muscular 
mass and reducing the adipose tissue. In the EU, Directive 96/22/EC prohibits the use of beta-agonists in 
food producing animals except for well-defined therapeutic purposes and under strict veterinary control. 
However some of them are allowed in countries such as Japan, the United States, Canada and several 
countries in South America. Doses effectively used as repartioning agent are a factor 10 times higher than 
the recommended therapeutic dose. These compounds act as growth promoting and repartioning agents in 
many species including cattle, sheep, swine, poultry and man (Witkamp, 1996) [5].
In the 90’s several outbreaks of food poisoning were reported after the consumption of meat contaminated 
with clenbuterol in Spain, France and Italy. In Portugal there were some well-known cases of human 
intoxication (four cases of acute food poisoning involving a total of 50 people) after consuming contaminated 
lamb and bovine meat containing residues of clenbuterol, which were reported some years ago. The period 
in which these poisonings occurred was between 1998 and 2002 (Barbosa et al.,2005) [1].
The impact on the health and welfare of the animals treated with such high con centration of betaagonist is 
poor, nevertheless some reports of known changes in the behavior. Some large companies for food services in 
the USA agree, this year, to work with its suppliers to eliminate the use of this kind of compounds, hormones 
and feed additives that it says are harmful to animals, including zilpaterol and ratopamine. The pledges are 
part of a new set of animal welfare principles that have been developed in collaboration with animal welfare 
and protection organization the Humane Society of the United States (HSUS) (Searby, L.) [4].
Material and Methods
In order to protect consumers inside the EU, there are official programs, national and from the community. 
These programs include the survey of animals on farms, in slaughterhouses and at borders, and often serve 
to support the health inspection of slaughterhouses, essential elements for ensuring the quality of the meat 
that is consumed. Selection of the most appropriated sample is important. On farms drinking water and feed 
are the ideal samples for control once beta-agonists demand the oral administration for the repartioning 
effect. Urine is the most used, especially for control of usage in live animals, but the levels are low within a 
short time of withdrawal and cleared rapidly from the body. Other no conventional sample is hair.
Organs, namely liver, wich accumulate beta-agonists are more suitable for monitoring usage (Boyd et 
al.1996) [3]. Other organs, such as lung and eye are very popular samples for research. For the control of 
veterinary drug residues we generally use two types of methods: screening and confirmatory. The most 
widely used screening tests are immunoassays, namely ELISA, and by now there are several commercially 
available kits for a large number of molecules. LC-MS/MS (BVL, 2006) [2], for screening and confirmatory 
purposes became in the last years a very robust method with high specificity and sensitivity that allows to 
analyze a large number of compounds (clenbuterol, salbutamol, ractopamine, zilpaterol and many others) 
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and simultaneously corticosteroids used in several countries as illegal growth promoters in association with 
beta-agonists.
Results and Discussion
Results from the official controls can be found in EFSA website. Concerning the non biological samples, 
the number of positive results and the concentration found are much lower than in the previous decade and 
only clenbuterol and ractopamine were found. Although animal feed have been analyzed, they have been 
encountered only in animal drinking water. On the other hand, there are currently no cases reported on 
human health associated with consumption of meat contaminated with beta-agonists in Portugal.
Conclusions
The economic pressure that has led to illegal use of beta-agonists by livestock producers is probably the 
same that will lead to its disappearance in the food chain.
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Risk Assessment and risk communication of foodborne pathogens
48. Risk-based approach for food safety applied to pork value chain in Vietnam 
Nguyen-Viet, H.1; Sinh, D. X. 2; Hanh 2, T. T. T.; Unger 1, F.; Grace, D. 1;  Phuc, P. D. 2; Makita, K. 3
Food-borne disease is a major public health issue in Vietnam. The contamination of popular 
foods can occur all along the food value chain. It is important to understand how and where food 
safety issues arise to mitigate and prevent food-borne diseases. Risk-based approach is a tool for 
managing food safety, however in Vietnam it is rarely applied and the capacity for application is 
still lacking however risk-based approach it is rarely applied and the capacity for application is still 
lacking. This paper describes the risk assessment training and research for pork along pig value 
chain in Vietnam. Risk assessment short courses and training curriculum were developed and 
taught at universities to strengthen the risk assessment capacity of partners. In parallel and after 
the training, risk assessment case studies were conducted to assess health risks related to pork 
consumption in the context of a pig smallholder value chain and pork traded in informal markets. 
Microbial (Salmonella) in 1275 porkand environmental samples collected at farm, slaughterhouse, and 
market and consumption level were analyzed. Pork consumption behavior and cross-contamination 
modalities during pork preparation were assessed. Chemical hazards (antibiotic and heavy metal 
residues) in 190 pork samples from markets were also analyzed. Results showed that Salmonella 
contamination in carcass swab in slaughterhouse was 39%, and in the final pork at market 45% 
with an average concentration of 9 MPN/g was recorded. 50% and 16.7% pooled samples were 
positive with sulfamethazine and chloramphenicol, with an average residue level of 156µg/kg and 
0.54 µg/kg respectively. A quantitative risk modeling is being developed and integrates information 
on contamination along the pork value chain to characterize the health risk caused by Salmonella. 
Results of risk modeling will be presented and risk mitigation options discussed.
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